Evidence map›Paper›PMID 41693837›Full record

ArticleACS polymers Au2026

Blended and Microparticle Composite Hyaluronan Hydrogels with Programmable Degradation through Selective Oxidation.

Melanie Grimm, Fiona Ye Rojo Acero, Fatemeh Safari, Desiré Venegas-Bustos, Andreas Wagner, Clara Presciutti, Wen Chen, Matteo D'Este, Jacek K Wychowaniec

Abstract read
In one paragraph

Article in ACS polymers Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Melanie GrimmAO Research Institute Davos, Clavadelerstrasse 8, Davos 7270, Switzerland.
Fiona Ye Rojo AceroAO Research Institute Davos, Clavadelerstrasse 8, Davos 7270, Switzerland.
Fatemeh SafariAO Research Institute Davos, Clavadelerstrasse 8, Davos 7270, Switzerland.
Desiré Venegas-BustosBioforge Lab, LaDIS, CIBER-BBN, Edificio LUCIA, Universidad de Valladolid, Valladolid 47011, Spain.
Andreas WagnerAnton Paar GmbH, Anton-Paar-Str. 20, 8054 Graz, Austria.
Clara PresciuttiAO Research Institute Davos, Clavadelerstrasse 8, Davos 7270, Switzerland.
Wen ChenAO Research Institute Davos, Clavadelerstrasse 8, Davos 7270, Switzerland.
Matteo D'EsteAO Research Institute Davos, Clavadelerstrasse 8, Davos 7270, Switzerland.ORCID https://orcid.org/0000-0002-0424-8172
Jacek K WychowaniecAO Research Institute Davos, Clavadelerstrasse 8, Davos 7270, Switzerland.ORCID https://orcid.org/0000-0002-6597-5242

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The design space of hydrogels for biomedical applications embraces a wide variety of parameters that can be tuned through chemical modification. Among them, tissue adhesion and viscoelastic properties contribute to the integration of tissue-engineered constructs with native tissues, while the degradation profile determines their temporal evolution and cell invasion. Selective 1,2-diol oxidation is a versatile tool to control all of these properties in polysaccharide-based hydrogels by generating aldehyde groups. A key challenge in implementing this tool is that although aldehyde groups improved adhesion, they also promoted chain fragmentation, demanding a trade-off. To address this, we devised a strategy that leverages the adhesiveness of oxidized biopolymers together with the mechanical stability of their nonoxidized counterparts. Here, we synthesized tyramine-modified hyaluronan (THA) and its oxidized form (oTHA) and evaluated their degradation and adhesion in various combinations and formats, including

Indexed as

degradationhydrogelsmolecular weightoxidationtyramine-modified hyaluronan

Identifiers

PMID41693837
PMCPMC12903431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.